Emmaus Life Sciences (EMMA) 10-K 2012 FY Annual report

Exhibit 32.1

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

In connection with the Annual Report on Form 10-K of CNS Response, Inc. (the “Company”) for the year ended September 30, 2012, as filed with the Securities and Exchange Commission (the “Report”), I, George Carpenter, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act.
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/George Carpenter

George Carpenter

Chief Executive Officer

January 15, 2013

  A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

This certification is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.  This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.